GenomicsScience Translational MedicinePeer-reviewed
Detection of residual disease after neoadjuvant therapy in breast cancer using personalized circulating tumor DNA analysis
Bradon R. McDonald, Tania Contente‐Cuomo, Stephen‐John Sammut…·Muhammed Murtaza
A personalized ctDNA test achieves high accuracy for residual disease detection after neoadjuvant therapy in breast cancer.
306 citationstop 1%